| Dr Jerry Alan Rubin, MD | |
|
6900 Turkey Lake Rd, Suite 1-7, Orlando, FL 32819-4707 | |
| (321) 939-3300 | |
| (321) 939-3303 |
| Full Name | Dr Jerry Alan Rubin |
|---|---|
| Gender | Male |
| Speciality | Hand Surgery |
| Experience | 40 Years |
| Location | 6900 Turkey Lake Rd, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134136997 | NPI | - | NPPES |
| 25310Y | Other | FL | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2082S0105X | Plastic Surgery - Surgery Of The Hand | ME 66320 (Florida) | Primary |
| Entity Name | Jerry A Rubin Md |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932351178 PECOS PAC ID: 0143377390 Enrollment ID: O20090409000144 |
News Archive
A new program project grant from the National Cancer Institute will fund research by the Translational Center of Excellence for Lung Cancer Immunology at the Abramson Cancer Center of the University of Pennsylvania to improve the effectiveness of chimeric antigen receptor T cell therapy at fighting solid tumors.
A new understanding of specialized incretin (or gut) hormones may lead to significant advances in the treatment and management of type 2 diabetes. This conclusion and other recent research were reported recently at the 14th Annual Meeting and Clinical Congress of the American Association for Clinical Endocrinologists (AACE) in Washington, DC.
"As we mark World [Tuberculosis (TB)] Day on Sunday March 24, there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat - one that must be urgently addressed," John Lechleiter, chair, president and CEO of Eli Lilly and Company and chair of the board of PhRMA, writes in a Forbes opinion piece, adding, "With resistance spreading, we need a renewed global commitment that combines public and private efforts to defeat TB."
The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, is increasing its investment in understanding the potential health, safety and environmental issues related to tiny particles that are used in many everyday products such as sunscreens, cosmetics and electronics. The NIEHS will award about $13 million over a two-year period, through the American Recovery and Reinvestment Act, to bolster the NIEHS's ongoing research portfolio in the area of engineered nanomaterials (ENMs).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jerry Alan Rubin, MD 6900 Turkey Lake Rd, Suite 1-7, Orlando, FL 32819-4707 Ph: (321) 939-3300 | Dr Jerry Alan Rubin, MD 6900 Turkey Lake Rd, Suite 1-7, Orlando, FL 32819-4707 Ph: (321) 939-3300 |
News Archive
A new program project grant from the National Cancer Institute will fund research by the Translational Center of Excellence for Lung Cancer Immunology at the Abramson Cancer Center of the University of Pennsylvania to improve the effectiveness of chimeric antigen receptor T cell therapy at fighting solid tumors.
A new understanding of specialized incretin (or gut) hormones may lead to significant advances in the treatment and management of type 2 diabetes. This conclusion and other recent research were reported recently at the 14th Annual Meeting and Clinical Congress of the American Association for Clinical Endocrinologists (AACE) in Washington, DC.
"As we mark World [Tuberculosis (TB)] Day on Sunday March 24, there can be no denying that TB, fueled by drug resistance, continues to pose a serious global health threat - one that must be urgently addressed," John Lechleiter, chair, president and CEO of Eli Lilly and Company and chair of the board of PhRMA, writes in a Forbes opinion piece, adding, "With resistance spreading, we need a renewed global commitment that combines public and private efforts to defeat TB."
The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, is increasing its investment in understanding the potential health, safety and environmental issues related to tiny particles that are used in many everyday products such as sunscreens, cosmetics and electronics. The NIEHS will award about $13 million over a two-year period, through the American Recovery and Reinvestment Act, to bolster the NIEHS's ongoing research portfolio in the area of engineered nanomaterials (ENMs).
› Verified 4 days ago
Dr. Christopher Dean Prevel, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5979 Vineland Rd, Suite 114, Orlando, FL 32819 Phone: 407-352-1818 Fax: 407-352-1814 | |
Dr. Kenrick Anthony Spence I, M.D., F.A.C.S. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 130 Hillcrest St, Orlando, FL 32801 Phone: 407-999-2585 Fax: 407-999-2628 | |
Dr. Luis Alejandro Jaramillo, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14050 Town Loop Blvd, Suite 204, Orlando, FL 32837 Phone: 407-251-8800 | |
Dr. Angelo Alberto Leto Barone, Plastic Surgery Medicare: Medicare Enrolled Practice Location: 6535 Nemours Pkwy, Orlando, FL 32827 Phone: 407-567-4000 Fax: 407-567-5924 | |
Dr. Florencio Jorge Gonzalez, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3100 Clay Ave, Suite # 299, Orlando, FL 32804 Phone: 407-447-1628 | |
Dr. Omar E Beidas, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 265 E Rollins St Ste 5300, Orlando, FL 32804 Phone: 407-821-3555 Fax: 407-821-3556 |